SE9201188L - New use - Google Patents

New use

Info

Publication number
SE9201188L
SE9201188L SE9201188A SE9201188A SE9201188L SE 9201188 L SE9201188 L SE 9201188L SE 9201188 A SE9201188 A SE 9201188A SE 9201188 A SE9201188 A SE 9201188A SE 9201188 L SE9201188 L SE 9201188L
Authority
SE
Sweden
Prior art keywords
new use
treatment
mso2ch
mso2
nch3
Prior art date
Application number
SE9201188A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE9201188D0 (en
SE506509C2 (en
Inventor
E Sjoelund
Original Assignee
Hydro Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hydro Pharma Ab filed Critical Hydro Pharma Ab
Priority to SE9201188A priority Critical patent/SE506509C2/en
Publication of SE9201188D0 publication Critical patent/SE9201188D0/en
Priority to PCT/SE1993/000276 priority patent/WO1993020817A1/en
Priority to AU39640/93A priority patent/AU3964093A/en
Publication of SE9201188L publication Critical patent/SE9201188L/en
Publication of SE506509C2 publication Critical patent/SE506509C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Abstract

The use of a compound of formula (I) wherein R is: a) -(CH2)mSO2(CH2)nCH3 where m = 2-3 and n = 0-1; or b) -(CH2)mSO2CH(CH3)2 where m = 2-3 for the preparation of a pharmaceutical composition for the treatment, especially the topical treatment, of inflammatory and/or infectious skin conditions.
SE9201188A 1992-04-14 1992-04-14 Use of imidazoles for the preparation of a pharmaceutical formulation for the treatment of inflammatory and / or infectious skin diseases SE506509C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9201188A SE506509C2 (en) 1992-04-14 1992-04-14 Use of imidazoles for the preparation of a pharmaceutical formulation for the treatment of inflammatory and / or infectious skin diseases
PCT/SE1993/000276 WO1993020817A1 (en) 1992-04-14 1993-03-31 Novel use of nitroimidazoles
AU39640/93A AU3964093A (en) 1992-04-14 1993-03-31 Novel use of nitroimidazoles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201188A SE506509C2 (en) 1992-04-14 1992-04-14 Use of imidazoles for the preparation of a pharmaceutical formulation for the treatment of inflammatory and / or infectious skin diseases

Publications (3)

Publication Number Publication Date
SE9201188D0 SE9201188D0 (en) 1992-04-14
SE9201188L true SE9201188L (en) 1993-10-15
SE506509C2 SE506509C2 (en) 1997-12-22

Family

ID=20385961

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201188A SE506509C2 (en) 1992-04-14 1992-04-14 Use of imidazoles for the preparation of a pharmaceutical formulation for the treatment of inflammatory and / or infectious skin diseases

Country Status (3)

Country Link
AU (1) AU3964093A (en)
SE (1) SE506509C2 (en)
WO (1) WO1993020817A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
AU773881B2 (en) * 1999-07-16 2004-06-10 Shoei Co., Ltd. Nitroimidazole external preparations for dermatosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006888A1 (en) * 1987-03-20 1988-09-22 Curatek Pharmaceuticals, Inc. Novel topical metronidazole formulations and therapeutic uses thereof
ATE194492T1 (en) * 1990-08-16 2000-07-15 Bloom Leonard TOPICAL TREATMENT OF BLEPHARITIS

Also Published As

Publication number Publication date
SE9201188D0 (en) 1992-04-14
WO1993020817A1 (en) 1993-10-28
SE506509C2 (en) 1997-12-22
AU3964093A (en) 1993-11-18

Similar Documents

Publication Publication Date Title
ES2190469T3 (en) ISOCUMARINE DERIVATIVES AND ITS USE IN PHARMACOS.
DE69010139D1 (en) Hair restorative.
FI972580A0 (en) Preparations and procedures for reducing skin irritation
ATE71095T1 (en) AZOLYLMETHYLOXIRANES - THEIR PRODUCTION AND USE AS PLANT PROTECTION AGENTS.
ES2063097T3 (en) SALBOSTATIN GLYCOSIDASE INHIBITOR, PROCEDURE FOR ITS PREPARATION AND USE.
FI935944A0 (en) Pyrazolopyrimidine- as well as pyrimidinylbisphosphonate as an anti-inflammatory
FI911286A0 (en) CHEMICAL FOERENINGAR.
SE9004060D0 (en) BENZZEPINE AND BENSOTIAZEPINE DERIVATE
DE69330625D1 (en) Topical antibacterial
BR9304780A (en) Compound, process for preparing the compound, pharmaceutical composition and use
SE9201188L (en) New use
ATE99942T1 (en) DEHYDROCHOLECALCIFEROL DERIVATIVES.
KR880007070A (en) Pharmaceutical composition for cataract treatment
FI20021652A (en) Intermediates useful in the preparation of alkyl derivatives of trazodone
FI930092A0 (en) INDANOPYRROLIDINKARBAMATER
ATE18554T1 (en) OPTICALLY ACTIVE IMIDAZOLYLPROPANOL COMPOUNDS AND THEIR PREPARATION AND APPLICATION.
SU1774617A1 (en) DERIVATIVES 3-CHLOR-1,4-NAFTOHINON OWING BACTERICIDAL AND FUNGICIDAL PROPERTIES
IT8604837V0 (en) FAN PERFECTED FOR THE AREATION OF CLOSED ENVIRONMENTS

Legal Events

Date Code Title Description
NUG Patent has lapsed